AU2001295732A1 - Concatenated nucleic acid sequences - Google Patents
Concatenated nucleic acid sequencesInfo
- Publication number
- AU2001295732A1 AU2001295732A1 AU2001295732A AU9573201A AU2001295732A1 AU 2001295732 A1 AU2001295732 A1 AU 2001295732A1 AU 2001295732 A AU2001295732 A AU 2001295732A AU 9573201 A AU9573201 A AU 9573201A AU 2001295732 A1 AU2001295732 A1 AU 2001295732A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- acid sequences
- concatenated nucleic
- concatenated
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0025144.7A GB0025144D0 (en) | 2000-10-13 | 2000-10-13 | Concatenated nucleic acid sequences |
| GB0025144 | 2000-10-13 | ||
| GB0025144.7 | 2000-10-13 | ||
| PCT/GB2001/004615 WO2002030945A2 (en) | 2000-10-13 | 2001-10-15 | Concatenated nucleic acid sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001295732A1 true AU2001295732A1 (en) | 2002-04-22 |
Family
ID=9901240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001295732A Abandoned AU2001295732A1 (en) | 2000-10-13 | 2001-10-15 | Concatenated nucleic acid sequences |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040009507A1 (en) |
| EP (1) | EP1325119A2 (en) |
| AU (1) | AU2001295732A1 (en) |
| GB (1) | GB0025144D0 (en) |
| WO (1) | WO2002030945A2 (en) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7871799B2 (en) | 2002-11-22 | 2011-01-18 | Lawrence Livermore National Security, Llc | Sequential addition of short DNA oligos in DNA-polymerase-based synthesis reactions |
| US20090005257A1 (en) | 2003-05-14 | 2009-01-01 | Jespers Laurent S | Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire |
| MY146381A (en) | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
| CL2007002567A1 (en) | 2006-09-08 | 2008-02-01 | Amgen Inc | ISOLATED PROTEINS FROM LINK TO ACTIVINE TO HUMAN. |
| JP2008289483A (en) * | 2007-05-25 | 2008-12-04 | Symphogen As | Screening of transformant expressable in eukaryote system |
| CL2008001887A1 (en) | 2007-06-29 | 2008-10-03 | Amgen Inc | PROTEINS OF UNION TO ANTIGEN THAT JOIN THE RECEPTOR ACTIVATED BY PROTEASES 2 (PAR-2); NUCLEIC ACID THAT CODES THEM; VECTOR AND GUEST CELL; METHOD OF PRODUCTION; AND COMPOSITION THAT UNDERSTANDS THEM. |
| US7982016B2 (en) | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| US8017328B2 (en) * | 2008-11-21 | 2011-09-13 | Agilent Technologies, Inc. | Genome partitioning using a nicking endonuclease |
| JP5498566B2 (en) | 2009-03-20 | 2014-05-21 | アムジェン インコーポレイテッド | Alpha-4-beta-7 heterodimer specific antagonist antibody |
| EP2459213A1 (en) | 2009-07-31 | 2012-06-06 | Amgen Inc. | Polypeptides that bind tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
| WO2011050000A2 (en) * | 2009-10-20 | 2011-04-28 | The Regents Of The University Of California | Single molecule nucleic acid nanoparticles |
| UA109888C2 (en) | 2009-12-07 | 2015-10-26 | ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES | |
| US9517264B2 (en) | 2010-04-15 | 2016-12-13 | Amgen Inc. | Human FGF receptor and β-Klotho binding proteins |
| CN103221426B (en) | 2010-08-16 | 2016-01-13 | 安姆根公司 | In conjunction with the antibody of myostatin, composition and method |
| CA2825894C (en) | 2011-02-02 | 2021-11-30 | Amgen Inc. | Prognosis of cancer using a circulating biomarker |
| US9574002B2 (en) | 2011-06-06 | 2017-02-21 | Amgen Inc. | Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor |
| US10634589B2 (en) | 2011-10-26 | 2020-04-28 | Amgen Inc. | Methods of reducing or eliminating protein modification and degradation arising from exposure to UV light |
| EP2847219A1 (en) | 2012-05-07 | 2015-03-18 | Amgen Inc. | Anti-erythropoietin antibodies |
| US9175082B2 (en) | 2012-05-31 | 2015-11-03 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind PD-L1 |
| EP2863946A4 (en) | 2012-06-21 | 2016-04-13 | Sorrento Therapeutics Inc | Antigen binding proteins that bind c-met |
| JP6438391B2 (en) | 2012-06-22 | 2018-12-12 | ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | Antigen binding protein that binds to CCR2 |
| WO2014004549A2 (en) | 2012-06-27 | 2014-01-03 | Amgen Inc. | Anti-mesothelin binding proteins |
| WO2014022102A1 (en) | 2012-08-01 | 2014-02-06 | Amgen Inc. | Methods of using anti-apoptotic compounds to modulate one or more properties of a cell culture |
| WO2014109858A1 (en) | 2013-01-14 | 2014-07-17 | Amgen Inc. | Methods of using cell-cycle inhibitors to modulate one or more properties of a cell culture |
| CN105431455A (en) | 2013-02-01 | 2016-03-23 | 圣塔玛丽亚生物疗法公司 | Administration of an anti-activin-a compound to a subject |
| US20160025749A1 (en) | 2013-03-11 | 2016-01-28 | Amgen Inc. | Protein formulations |
| WO2014159764A1 (en) | 2013-03-14 | 2014-10-02 | Amgen Inc. | Chrdl-1 antigen binding proteins and methods of treatment |
| EP3063287A1 (en) | 2013-10-31 | 2016-09-07 | Amgen Inc. | Use of monensin to regulate glycosylation of recombinant proteins |
| US10106829B2 (en) | 2014-01-29 | 2018-10-23 | Amgen Inc. | Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins |
| WO2015116315A1 (en) | 2014-01-29 | 2015-08-06 | Amgen Inc. | Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins |
| MA45695A (en) | 2014-08-22 | 2019-05-22 | Sorrento Therapeutics Inc | CXCR3 ANTIGEN-BIND PROTEINS |
| WO2016040767A2 (en) | 2014-09-12 | 2016-03-17 | Amgen Inc. | Chrdl-1 epitopes and antibodies |
| US20170233467A1 (en) | 2014-10-17 | 2017-08-17 | Amgen Inc. | Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 for Ocular Therapies |
| CN105669863B (en) | 2014-12-05 | 2019-09-13 | 鸿运华宁（杭州）生物医药有限公司 | It is a kind of can with human endothelin receptor specifically bind antibody and its application |
| EP4151231A1 (en) | 2015-02-13 | 2023-03-22 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind ctla4 |
| AU2016229087A1 (en) | 2015-03-10 | 2017-09-28 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind PSMA |
| WO2016164656A1 (en) | 2015-04-08 | 2016-10-13 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind cd38 |
| EP4435105A2 (en) | 2015-09-29 | 2024-09-25 | Amgen Inc. | Asgr inhibitors for reduzing cholesterol levels |
| JP6883590B2 (en) | 2016-01-29 | 2021-06-09 | ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | Antigen-binding protein that binds to PD-L1 |
| MA44976A (en) | 2016-05-11 | 2019-03-20 | Amgen Inc | DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEIN USING INTRAGENIC GLUTAMINE SYNTHETASE SUPPLEMENTATION VECTORS |
| TWI826351B (en) | 2016-05-31 | 2023-12-21 | 大陸商鴻運華寧（杭州）生物醫藥有限公司 | R antibodies, their pharmaceutical compositions and uses |
| CN117126279A (en) | 2018-03-20 | 2023-11-28 | 鸿运华宁（杭州）生物医药有限公司 | GIPR antibody and fusion protein of GIPR antibody and GLP-1, and pharmaceutical composition and application thereof |
| CN110357959B (en) | 2018-04-10 | 2023-02-28 | 鸿运华宁（杭州）生物医药有限公司 | GCGR antibody, fusion protein of GCGR antibody and GLP-1, and pharmaceutical composition and application of GCGR antibody and fusion protein |
| CN110655577A (en) | 2018-06-13 | 2020-01-07 | 鸿运华宁（杭州）生物医药有限公司 | APJ antibody and fusion protein thereof with Elabela, and pharmaceutical composition and application thereof |
| EP4283295A3 (en) | 2019-04-30 | 2024-03-06 | Gigagen, Inc. | Recombinant polyclonal proteins and methods of use thereof |
| CN112239507A (en) | 2019-07-17 | 2021-01-19 | 鸿运华宁（杭州）生物医药有限公司 | Fusion protein of ETA antibody and TGF-beta Trap, and pharmaceutical composition and application thereof |
| CN112521501A (en) | 2019-09-18 | 2021-03-19 | 鸿运华宁（杭州）生物医药有限公司 | GIPR antibody and fusion protein thereof with GLP-1, and pharmaceutical composition and application thereof |
| KR20220110810A (en) | 2019-12-05 | 2022-08-09 | 소렌토 쎄라퓨틱스, 인코포레이티드 | Compositions and methods comprising an anti-CD47 antibody in combination with a tumor targeting antibody |
| JP2023515573A (en) | 2020-02-26 | 2023-04-13 | ソレント・セラピューティクス・インコーポレイテッド | Activatable antigen binding proteins with universal shielding moieties |
| WO2021195089A1 (en) | 2020-03-23 | 2021-09-30 | Sorrento Therapeutics, Inc. | Fc-coronavirus antigen fusion proteins, and nucleic acids, vectors, compositions and methods of use thereof |
| US20230167191A1 (en) | 2020-04-24 | 2023-06-01 | Sorrento Therapeutics, Inc. | Memory Dimeric Antigen Receptors (mDARs) |
| CA3175960A1 (en) | 2020-04-24 | 2021-10-28 | Henry Hongjun Ji | Lateral flow device for detection of coronavirus infection |
| WO2021253002A1 (en) | 2020-06-12 | 2021-12-16 | Gigagen, Inc. | Recombinant polyclonal proteins targeting covid-19 and methods of use thereof |
| US20230235059A1 (en) | 2020-06-26 | 2023-07-27 | Sorrento Therapeutics, Inc. | Anti-pd1 antibodies and uses thereof |
| WO2022031834A1 (en) | 2020-08-05 | 2022-02-10 | Gigagen, Inc. | Recombinant polyclonal proteins targeting zika and methods of use thereof |
| TW202233660A (en) | 2020-10-30 | 2022-09-01 | 美商安進公司 | Overexpression of insulin-like growth factor receptor mutants to modulate igf supplementation |
| CA3196874A1 (en) | 2020-11-04 | 2022-05-12 | Henry Hongjun Ji | Lateral flow devices for high sensitivity detection of coronavirus infection, and methods of making and using the same |
| WO2022192594A2 (en) | 2021-03-11 | 2022-09-15 | Sorrento Therapeutics, Inc. | Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease |
| CN115141276A (en) | 2021-03-31 | 2022-10-04 | 鸿运华宁（杭州）生物医药有限公司 | Antibody capable of being specifically combined with human endothelin receptor and application thereof in treatment of diabetic nephropathy and chronic nephropathy |
| WO2022261262A1 (en) | 2021-06-09 | 2022-12-15 | Sorrento Therapeutics, Inc. | Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device |
| TW202328442A (en) | 2021-09-10 | 2023-07-16 | 美商安進公司 | Adaptation of platform hosts to igf- media |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4403036A (en) * | 1980-12-02 | 1983-09-06 | University Of Iowa Research Foundation | Genetic reagents for generating plasmids containing multiple copies of DNA segments |
| US5830713A (en) * | 1986-11-04 | 1998-11-03 | Protein Polymer Technologies, Inc. | Methods for preparing synthetic repetitive DNA |
| US5030566A (en) * | 1989-01-04 | 1991-07-09 | Board Of Regents, The University Of Texas System | Concatemeric DNA length standards |
| US5023171A (en) * | 1989-08-10 | 1991-06-11 | Mayo Foundation For Medical Education And Research | Method for gene splicing by overlap extension using the polymerase chain reaction |
| DE3936258C1 (en) * | 1989-10-31 | 1991-04-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De | |
| ATE463573T1 (en) * | 1991-12-02 | 2010-04-15 | Medimmune Ltd | PRODUCTION OF AUTOANTIBODIES ON PHAGE SURFACES BASED ON ANTIBODIES SEGMENT LIBRARIES |
| AU672969B2 (en) * | 1992-03-10 | 1996-10-24 | United States of America, as represented by The Secretary, Department of Health & Human Services, The | Exchangeable template reaction |
| DE4428651C1 (en) * | 1994-08-12 | 1996-02-29 | Inst Molekulare Biotechnologie | Process for the production and amplification of nucleic acids |
| US5648245A (en) * | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
| FR2738841B1 (en) * | 1995-09-15 | 1997-11-21 | Centre Nat Rech Scient | PROCESS FOR THE POLYMERIZATION OF NUCLEIC ACID SEQUENCES AND ITS APPLICATIONS |
| US5756316A (en) * | 1995-11-02 | 1998-05-26 | Genencor International, Inc. | Molecular cloning by multimerization of plasmids |
| ATE238434T1 (en) * | 1995-12-05 | 2003-05-15 | Jorn Erland Koch | A CASCADED DUPLICATION REACTION OF NUCLEIC ACIDS |
| JP3415995B2 (en) * | 1996-06-10 | 2003-06-09 | 科学技術振興事業団 | Method for producing high molecular micro gene polymer |
| GB0018120D0 (en) * | 2000-07-24 | 2000-09-13 | Fermentas Ab | Nuclease |
-
2000
- 2000-10-13 GB GBGB0025144.7A patent/GB0025144D0/en not_active Ceased
-
2001
- 2001-10-15 WO PCT/GB2001/004615 patent/WO2002030945A2/en not_active Application Discontinuation
- 2001-10-15 AU AU2001295732A patent/AU2001295732A1/en not_active Abandoned
- 2001-10-15 EP EP01976462A patent/EP1325119A2/en not_active Withdrawn
-
2003
- 2003-04-11 US US10/412,382 patent/US20040009507A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002030945A2 (en) | 2002-04-18 |
| WO2002030945A3 (en) | 2002-07-18 |
| EP1325119A2 (en) | 2003-07-09 |
| GB0025144D0 (en) | 2000-11-29 |
| US20040009507A1 (en) | 2004-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001295732A1 (en) | Concatenated nucleic acid sequences | |
| AU2002245184A1 (en) | Nucleic acid amplification | |
| AU2002325538A1 (en) | Nucleic acid amplification methods | |
| AU2002257076A1 (en) | Nucleic acid shuffling | |
| AU2001261476A1 (en) | Nucleic acid sequences for novel gpcrs | |
| AU2001249098A1 (en) | Nucleic acid sequences associated with aging, particularly skin aging | |
| AU2001242625A1 (en) | Gene sequence | |
| AU2003281867A1 (en) | Antisense nucleic acids | |
| AU2001240791A1 (en) | Sequence | |
| AU2001278655A1 (en) | Novel nucleic acid and amino acid sequences | |
| AU2001264247A1 (en) | GASC1 gene | |
| AU2001240103A1 (en) | Reproduction-specific genes | |
| AU2001295841A1 (en) | Human dna sequences | |
| AU2002366435A1 (en) | Nucleic acid amplification | |
| AU2002310296A1 (en) | Rna purification methods | |
| AU2001288839A1 (en) | Self-rearranging dna vectors | |
| AUPQ749100A0 (en) | New epilespy gene | |
| AU2001252390A1 (en) | Nucleic acid immunization | |
| AU2001285743A1 (en) | Adipose-related gene | |
| AU7461900A (en) | Nucleotide sequences | |
| AU2001253485A1 (en) | Nucleic acid sequences associated with baldness | |
| AU2002347346A1 (en) | Dna vaccine | |
| AU2001276406A1 (en) | Apoptosis-inducing dna sequences | |
| AUPR223500A0 (en) | Nucleic acid sequence | |
| AU2002314927A1 (en) | Nucleic acid regulatory sequences and uses therefor |